FDA Inspection 1233249 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on February 22, 2024 in Las Cruces, NM. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 22, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Las Cruces, NM (United States)